Cargando…
Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Mosby, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849591/ http://dx.doi.org/10.1016/j.jaci.2020.12.603 |
| _version_ | 1783645337035997184 |
|---|---|
| author | Kang, Lois Goldman, Maya Uyehara, Anny Goldman, Michael |
| author_facet | Kang, Lois Goldman, Maya Uyehara, Anny Goldman, Michael |
| author_sort | Kang, Lois |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7849591 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Mosby, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78495912021-02-02 Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic Kang, Lois Goldman, Maya Uyehara, Anny Goldman, Michael J Allergy Clin Immunol Article Published by Mosby, Inc. 2021-02 2021-02-01 /pmc/articles/PMC7849591/ http://dx.doi.org/10.1016/j.jaci.2020.12.603 Text en Copyright © 2020 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Kang, Lois Goldman, Maya Uyehara, Anny Goldman, Michael Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic |
| title | Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic |
| title_full | Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic |
| title_fullStr | Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic |
| title_full_unstemmed | Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic |
| title_short | Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic |
| title_sort | safe subcutaneous immunotherapy dosing adjustments following prolonged interruptions in therapy due to covid-19 pandemic |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849591/ http://dx.doi.org/10.1016/j.jaci.2020.12.603 |
| work_keys_str_mv | AT kanglois safesubcutaneousimmunotherapydosingadjustmentsfollowingprolongedinterruptionsintherapyduetocovid19pandemic AT goldmanmaya safesubcutaneousimmunotherapydosingadjustmentsfollowingprolongedinterruptionsintherapyduetocovid19pandemic AT uyeharaanny safesubcutaneousimmunotherapydosingadjustmentsfollowingprolongedinterruptionsintherapyduetocovid19pandemic AT goldmanmichael safesubcutaneousimmunotherapydosingadjustmentsfollowingprolongedinterruptionsintherapyduetocovid19pandemic |